BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30151439)

  • 1. Conceptual Approach of Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging in Chest Diseases.
    Coolen J
    J Belg Soc Radiol; 2016 Nov; 100(1):10. PubMed ID: 30151439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
    Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
    Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An initial study on the comparison of diagnostic performance of
    Wang ML; Zhang H; Yu HJ; Tan H; Hu LZ; Kong HJ; Mao WJ; Xiao J; Shi HC
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(1):16-23. PubMed ID: 36243657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of solitary pulmonary lesions combining visual perfusion and quantitative diffusion MR imaging.
    Coolen J; Vansteenkiste J; De Keyzer F; Decaluwé H; De Wever W; Deroose C; Dooms C; Verbeken E; De Leyn P; Vandecaveye V; Van Raemdonck D; Nackaerts K; Dymarkowski S; Verschakelen J
    Eur Radiol; 2014 Feb; 24(2):531-41. PubMed ID: 24173597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of diffusion-weighted imaging (DWI) in PET/MRI for head and neck cancer evaluation.
    Queiroz MA; Hüllner M; Kuhn F; Huber G; Meerwein C; Kollias S; von Schulthess G; Veit-Haibach P
    Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2212-21. PubMed ID: 25091219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted Imaging of the Chest: A Primer for Radiologists.
    Broncano J; Steinbrecher K; Marquis KM; Raptis CA; Royuela Del Val J; Vollmer I; Bhalla S; Luna A
    Radiographics; 2023 Jul; 43(7):e220138. PubMed ID: 37347699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective comparison of MR with diffusion-weighted imaging, endoscopic ultrasound, MDCT and positron emission tomography-CT in the pre-operative staging of oesophageal cancer: results from a pilot study.
    Giganti F; Ambrosi A; Petrone MC; Canevari C; Chiari D; Salerno A; Arcidiacono PG; Nicoletti R; Albarello L; Mazza E; Gallivanone F; Gianolli L; Orsenigo E; Esposito A; Staudacher C; Del Maschio A; De Cobelli F
    Br J Radiol; 2016 Dec; 89(1068):20160087. PubMed ID: 27767330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).
    Van Den Berghe T; Verstraete KL; Lecouvet FE; Lejoly M; Dutoit J
    Skeletal Radiol; 2022 Jan; 51(1):101-122. PubMed ID: 34523007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological whole-body staging in integrated (18)F-FDG PET/MR: Value of different MR sequences for simultaneous PET and MR reading.
    Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Beiderwellen K; Ruhlmann V; Umutlu L; Quick HH; Antoch G; Buchbender C
    Eur J Radiol; 2015 Jul; 84(7):1285-92. PubMed ID: 25975895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/CT versus MRI for diagnosis, staging, and follow-up of lung cancer.
    Kim HS; Lee KS; Ohno Y; van Beek EJ; Biederer J
    J Magn Reson Imaging; 2015 Aug; 42(2):247-60. PubMed ID: 25365936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DWI-MR and PET-CT Functional Imaging for Boost Tumor Volume Delineation in Neoadjuvant Rectal Cancer Treatment.
    Rosa C; Gasparini L; DI Guglielmo FC; Caravatta L; DI Tommaso M; Pizzi AD; Martino G; Castaldi P; Mazza R; Porreca A; DI Nicola M; Calcagni ML; Genovesi D
    In Vivo; 2023; 37(1):424-432. PubMed ID: 36593016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MR imaging using FASE sequence for 3T MR system: Preliminary comparison of capability for N-stage assessment by means of diffusion-weighted MR imaging using EPI sequence, STIR FASE imaging and FDG PET/CT for non-small cell lung cancer patients.
    Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Kassai Y; Yui M; Matsumoto S; Sugimura K
    Eur J Radiol; 2015 Nov; 84(11):2321-31. PubMed ID: 26231045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-weighted imaging of the chest.
    Luna A; Sánchez-Gonzalez J; Caro P
    Magn Reson Imaging Clin N Am; 2011 Feb; 19(1):69-94. PubMed ID: 21129636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-neoplastic diseases of the fallopian tube: MR imaging with emphasis on diffusion-weighted imaging.
    Foti PV; Ognibene N; Spadola S; Caltabiano R; Farina R; Palmucci S; Milone P; Ettorre GC
    Insights Imaging; 2016 Jun; 7(3):311-27. PubMed ID: 26992404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions.
    Jeong JH; Cho IH; Kong EJ; Chun KA
    Nucl Med Mol Imaging; 2014 Mar; 48(1):26-32. PubMed ID: 24900135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.